The international school “Novel psychoactive substances (NPS): new frontiers in addiction” has been held in Pula, nearby Cagliari (Sardinia, Italy) from October 10 to October 13 2017. This event has been chaired by Maria Antonietta De Luca, PhD, of the Department of Biomedical Sciences at University of Cagliari (Italy). MNS has offered support to the event in the form of 1 Travel Grant for a Young Researcher from the South and waived registration fees for all participating MNS members.
The advent of NPS has contributed to the appearance and growth of a new ‘drug scenario’ characterized by an increased number of drug users among youth and the consumption of drugs with unknown effects or safety profiles.
This International Scientific School provides a unique opportunity for graduate students, PhD students, and post-doctoral scientists in the early stages of their career to gain expertise in the field of NPS. This project has been funded by Sardegna Ricerche and the University of Cagliari in order to promote the study, monitoring and profiling of NPS, and prevent health damage and update relevant professionals.
In occasion of this event, the plenary Lecture of Prof. Michael Baumann, PhD (Designer Drug Research Unit -DDRU, NIDA, NIH, Baltimore, USA) held on the 10th October was filmed and made available in live streaming on the “Sardegna Ricerche” Youtube channel. Michael H. Baumann received his Ph.D. in Physiology and Neurobiology from Rutgers University in 1991, immediately after which he joined the NIDA IRP as a Staff Fellow in the laboratory of Dr. Richard B. Rothman. From 1991-2011, Mike and his colleagues elucidated the critical role of brain dopamine and serotonin in the mechanism of action for various therapeutic and abused stimulant drugs. In 2012, together with Dr. Newman, he established the Designer Drug Research Unit (DDRU). The main goals of the DDRU are to collect, analyze and disseminate current information about the pharmacology and toxicology of newly-emerging synthetic drugs of abuse (i.e., designer drugs). Working with partner organizations such as the Drug Enforcement Administration (DEA) and the Community Epidemiology Work Group (CEWG), Mike is kept informed about recent trends in designer drug use. Most recently, his laboratory has determined the molecular mechanism of action for several so-called “bath salts” cathinones.
MNS is happy to share with you again this excellent keynote at NPS Cagliari, in which Prof. Baumann speaks about “Neuropharmacology of newly-emerging synthetic stimulants: cathinones, phenetylamines, and beyond”.